BR9806280A - Grânulos compreendendo clavulaneto e um ou mais excipientes - Google Patents

Grânulos compreendendo clavulaneto e um ou mais excipientes

Info

Publication number
BR9806280A
BR9806280A BR9806280-8A BR9806280A BR9806280A BR 9806280 A BR9806280 A BR 9806280A BR 9806280 A BR9806280 A BR 9806280A BR 9806280 A BR9806280 A BR 9806280A
Authority
BR
Brazil
Prior art keywords
excipients
granules
clavulanide
clavulanate
understanding
Prior art date
Application number
BR9806280-8A
Other languages
English (en)
Inventor
Jan Willem Groenendaal
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of BR9806280A publication Critical patent/BR9806280A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

GRâNULOS COMPREENDENDO CLAVULANATO E UM OU MAIS EXCIPIENTES". Foram proporcionados grânulos contendo excipientes inertes para formulações farmacêuticas. Também um processo para preparar os mesmos, por emprego de um dispositivo de peneiramento usando, de preferência, um sistema de jato de ar, foi descrito.
BR9806280-8A 1997-11-17 1998-11-09 Grânulos compreendendo clavulaneto e um ou mais excipientes BR9806280A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17
PCT/EP1998/007225 WO1999025343A1 (en) 1997-11-17 1998-11-09 Granules comprising clavulanate and one or more excipients

Publications (1)

Publication Number Publication Date
BR9806280A true BR9806280A (pt) 2000-02-15

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806280-8A BR9806280A (pt) 1997-11-17 1998-11-09 Grânulos compreendendo clavulaneto e um ou mais excipientes

Country Status (13)

Country Link
EP (1) EP0973520A1 (pt)
JP (1) JP2001516365A (pt)
CN (1) CN1242705A (pt)
AU (1) AU1337999A (pt)
BR (1) BR9806280A (pt)
CA (1) CA2272402A1 (pt)
CO (1) CO4980893A1 (pt)
JO (1) JO2082B1 (pt)
NO (1) NO993467D0 (pt)
PL (1) PL334517A1 (pt)
TR (1) TR199901584T1 (pt)
WO (1) WO1999025343A1 (pt)
ZA (1) ZA9810499B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
CA2523079C (en) * 2003-05-02 2012-08-14 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
WO2009135946A1 (en) 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
EP2890366A1 (en) * 2012-08-28 2015-07-08 DSM Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at least one of them is in the form of mini-tablets
JP2014062064A (ja) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk バルサルタン含有錠剤の製造方法
JP6141472B2 (ja) * 2016-03-02 2017-06-07 大原薬品工業株式会社 バルサルタン含有錠剤の製造方法
US11504333B2 (en) 2017-07-05 2022-11-22 Novartis Ag Pharmaceutical composition
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
PL334517A1 (en) 2000-02-28
TR199901584T1 (xx) 2000-01-21
CN1242705A (zh) 2000-01-26
JP2001516365A (ja) 2001-09-25
NO993467L (no) 1999-07-14
ZA9810499B (en) 1999-05-24
CA2272402A1 (en) 1999-05-27
CO4980893A1 (es) 2000-11-27
WO1999025343A1 (en) 1999-05-27
JO2082B1 (en) 2000-05-21
NO993467D0 (no) 1999-07-14
AU1337999A (en) 1999-06-07
EP0973520A1 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
BR9806280A (pt) Grânulos compreendendo clavulaneto e um ou mais excipientes
FI955215A (fi) Hallitusti vapauttavat oksibutyniinivalmisteet
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
BR9610875A (pt) Modulares rxr seletivos - dimeros e processos para seu uso
DK0804166T3 (da) Formulering med kontrolleret frigivelse (Albuterol)
NO933854L (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
DE69432025T2 (de) Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden
BR9713734A (pt) Derivados de sulfonamidas, processo para sua preparação, e seu uso como medicamentos
BR9205852A (pt) Aparelho de radiotelefonia, e processo de seleção de sistema alternativo para aparelho de radiotelefonia
DE59409873D1 (de) Wirkstoffpflaster
ES2130423T3 (es) Sistema de administracion intravaginal.
DE69637947D1 (de) Multimerer, rekombinanter urease impfstoff
CO4410175A1 (es) Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion
NO982738D0 (no) Oppfinnelse og anordning for mikrogranuler, som inneholder diltiazem som aktivt prinsipp, for vedvarende frigj°ring
ZA9710243B (en) 3-Amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them.
BR9603124A (pt) Dipeptídeo processo para preparação do mesmo mistura e medicamentos
ATE219665T1 (de) Dosisformen und deren verwendungen
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU4861990A (en) Substituted benzo(b)pyrans, processes for their preparation, their use and pharmaceutical preparations based on these compounds
BR9403572A (pt) Composto, processo para sua preparação e formulação farmacêutica
AU6828890A (en) Herbicides containing an alkenyl or heteroarylthio, sulphone or sulphoxide group
NL1000767A1 (nl) Granulatie-apparatuur, granulatieprocedure en gegranuleerd produkt.
MX9203154A (es) Sistema terapeutico de liberacion regulada para formulaciones farmaceuticas liquidas.
BR9106284A (pt) Processo para preparar olibuteno de baixo peso molecular,e,polibuteno

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired